LONG-TERM OUTCOMES FOLLOWING A SWITCH FROM ORIGINATOR ADALIMUMAB TO THE BIOSIMILAR SB5 (IMRALDI) IN IBD

Heather Dolby  1     Nikolas Plevris     Laura Lucaciu     Caitlin Rees     Mathew Lyons     Spyridon Siakavellas     Nathan Constantine-Cook  2     Philip Jenkinson     Shanna Su     Claire O'Hare     Laura Kirkpatrick     Lynne Merchant     Gareth R Jones     Charlie W. Lees     Ian D Arnott     colin noble    
1 Western General Hospital, Edinburgh, United Kingdom
2 University of Edinburgh, Edinburgh, United Kingdom

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing